SUSMEDInc Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 0/6
SUSMEDInc has been growing earnings at an average annual rate of 7.8%, while the Healthcare Services industry saw earnings growing at 17.3% annually. Revenues have been growing at an average rate of 42.1% per year.
Key information
7.8%
Earnings growth rate
17.2%
EPS growth rate
| Healthcare Services Industry Growth | 19.2% |
| Revenue growth rate | 42.1% |
| Return on equity | -7.6% |
| Net Margin | -105.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How SUSMEDInc makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 340 | -357 | 452 | 240 |
| 31 Dec 23 | 732 | 49 | 446 | 233 |
| 30 Sep 23 | 531 | -104 | 420 | 209 |
| 30 Jun 23 | 530 | -50 | 394 | 176 |
| 31 Mar 23 | 525 | 2 | 370 | 145 |
| 31 Dec 22 | 128 | -335 | 349 | 144 |
| 30 Sep 22 | 317 | -196 | 337 | 164 |
| 30 Jun 22 | 316 | -233 | 309 | 226 |
| 30 Jun 21 | 115 | -277 | 190 | 249 |
| 30 Jun 20 | 34 | -96 | 107 | 86 |
Quality Earnings: 4263 is currently unprofitable.
Growing Profit Margin: 4263 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4263 is unprofitable, but has reduced losses over the past 5 years at a rate of 7.8% per year.
Accelerating Growth: Unable to compare 4263's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4263 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.9%).
Return on Equity
High ROE: 4263 has a negative Return on Equity (-7.56%), as it is currently unprofitable.